University of Pretoria
Pretoria, South Africa
Public university in Pretoria
Lynnwood Rd, Hatfield, Pretoria, 0002
About University of Pretoria
The University of Pretoria is a multi-campus public research university in Pretoria, the administrative and de facto capital of South Africa.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
7
Eli Lilly and Company
3
Boehringer Ingelheim
2
ECOG-ACRIN Cancer Research Group
1
International Atomic Energy Agency
1
OSI Pharmaceuticals
1
Pfizer
1
Regeneron Pharmaceuticals
1
Zymeworks Inc.
1
hearX Group
1
Clinical Trials at University of Pretoria
During the past decade, University of Pretoria conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 11 clinical trials were completed, i.e. on
average, 157.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
2000-05-19
2010-01-27
Completed
3,436
OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
2001-11-01
2004-01-30
Completed
731
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
2007-09-01
2014-07-01
Terminated
48
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Pretoria" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Eli Lilly and Company" with 3 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "International Atomic Energy Agency"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pretoria"
#1 collaborator was "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at University of Pretoria
According to Clinical.Site data, the most researched conditions in "University of Pretoria" are
"Breast Adenocarcinoma" (3 trials), "HER2/Neu Negative" (2 trials), "Stage IIIA Breast Cancer AJCC v7" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Carcinoma, Non-small-cell Lung" (1 trials). Many other conditions were trialed in "University of Pretoria" in a lesser frequency.
Clinical Trials Intervention Types at University of Pretoria
Most popular intervention types in "University of Pretoria" are "Drug" (17 trials), "Biological" (6 trials), "Other" (6 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (5 trials), "Bevacizumab" (4 trials), "Cisplatin" (4 trials), "Baricitinib" (3 trials) and "Capecitabine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University of Pretoria
The vast majority of trials in "University of Pretoria" are
18 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at University of Pretoria
Currently, there are NaN active trials in "University of Pretoria".
undefined are not yet recruiting,
1 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in University of Pretoria,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in University of Pretoria, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 2 trials that are defined as “Not Applicable".
Departments of University of Pretoria
University of Pretoria has several departments that took part in Clinical trials: "University of Pretoria Clinical Research Unit" - 11 trials, "University of Pretoria; Department of Medical Oncology" - 10 trials, "Steve Biko Academic Hospital; Oncology" - 7 trials
Departments List
Name
City
Trials